Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
MaxCyte Share News (MXCT)
MXCT Share
Price
MXCT Share
News
MXCT Share
Chat
MXCT Share
Trades63
MXCT
Live RNS
MXCT Share
Charts
MXCT Broker
Ratings
MXCT Directors
Deals
MXCT Financial
Diary
MXCT
Fundamentals
MXCT Short
Positions
MXCT
Media
MXCT Company
Research
MXCT Company
Timeline
- There is currently no data for MXCT
MaxCyte News
LONDON BRIEFING: Legal & General announces buyback after profit hike
(Alliance News) - London's FTSE 100 is called to open higher, shaking off mixed trade in Asia and another decline in New York.
MaxCyte reports wider loss, forecasts revenue growth in 2025
(Alliance News) - MaxCyte Inc on Tuesday said its annual loss widened amid higher costs and falling revenue, but it remains optimistic about growth pr...
MaxCyte signs SPL deal with TG Therapeutics
(Sharecast News) - MaxCyte announced the signing of a strategic platform licence agreement with TG Therapeutics on Wednesday, granting the biopharmace...
MaxCyte partners with TG Therapeutics on autoimmune cell therapy
(Alliance News) - MaxCyte Inc on Wednesday said it has signed a strategic platform licence with TG Therapeutics Inc to develop its autoimmune cell the...
MaxCyte announces acquisition of SeQure Dx
(Sharecast News) - MaxCyte announced on Thursday that it has acquired SeQure Dx, a specialist in on-target and off-target editing assessment services ...
MaxCyte buys gene therapy analytics firm SeQure Dx
(Alliance News) - MaxCyte Inc on Thursday said it has acquired SeQure Dx Inc, as it looks to improve its gene therapy testing process.
MaxCyte flags full-year revenue at top end of expectations
(Sharecast News) - Cell-engineering platform technology company MaxCyte said in an update on Friday that it expected core revenue for the fourth quart...
Follow the stocks
